291 related articles for article (PubMed ID: 25190487)
1. Upregulation of Limk1 caused by microRNA-138 loss aggravates the metastasis of ovarian cancer by activation of Limk1/cofilin signaling.
Chen P; Zeng M; Zhao Y; Fang X
Oncol Rep; 2014 Nov; 32(5):2070-6. PubMed ID: 25190487
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1.
Tan Y; Hu H; Tan W; Jin L; Liu J; Zhou H
Mol Med Rep; 2016 Nov; 14(5):4422-4428. PubMed ID: 27665963
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway.
Cai S; Chen R; Li X; Cai Y; Ye Z; Li S; Li J; Huang H; Peng S; Wang J; Tao Y; Huang H; Wen X; Mo J; Deng Z; Wang J; Zhang Y; Gao X; Wen X
Oncotarget; 2015 Feb; 6(6):3904-17. PubMed ID: 25714010
[TBL] [Abstract][Full Text] [Related]
4. DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion.
Zhou Y; Su J; Shi L; Liao Q; Su Q
Oncol Rep; 2013 Feb; 29(2):605-12. PubMed ID: 23233092
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1.
Yu HX; Wang XL; Zhang LN; Zhang J; Zhao W
Biomed Pharmacother; 2019 Jan; 109():751-761. PubMed ID: 30551528
[TBL] [Abstract][Full Text] [Related]
6. MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1.
Li D; Song H; Wu T; Xie D; Hu J; Zhao J; Shen Q; Fang L
Mol Cell Biochem; 2018 Jul; 444(1-2):169-178. PubMed ID: 29188531
[TBL] [Abstract][Full Text] [Related]
7. PI3K Catalytic Isoform Alteration Promotes the LIMK1-related Metastasis Through the PAK1 or ROCK1/2 Activation in Cigarette Smoke-exposed Ovarian Cancer Cells.
Park GB; Kim D
Anticancer Res; 2017 Apr; 37(4):1805-1818. PubMed ID: 28373445
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of LIMK1 promotes tumor growth and metastasis in gastric cancer.
You T; Gao W; Wei J; Jin X; Zhao Z; Wang C; Li Y
Biomed Pharmacother; 2015 Feb; 69():96-101. PubMed ID: 25661344
[TBL] [Abstract][Full Text] [Related]
9. MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1.
Zhou J; Liu R; Luo C; Zhou X; Xia K; Chen X; Zhou M; Zou Q; Cao P; Cao K
Cancer Biol Ther; 2014 Oct; 15(10):1340-9. PubMed ID: 25019203
[TBL] [Abstract][Full Text] [Related]
10. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
[TBL] [Abstract][Full Text] [Related]
11. MiR-509-3p Induces Apoptosis and Affects the Chemosensitivity of Cervical Cancer Cells by Targeting the RAC1/PAK1/LIMK1/Cofilin Pathway.
Xu J; Ma X; Yang H; Zhang J; Cai G; Yao N
Chem Pharm Bull (Tokyo); 2021; 69(4):325-332. PubMed ID: 33790078
[TBL] [Abstract][Full Text] [Related]
12. LIM kinase 1 is required for insulin‑dependent cell growth of osteosarcoma cell lines.
Zhang HS; Zhao JW; Wang H; Zhang HY; Ji QY; Meng LJ; Xing FJ; Yang ST; Wang Y
Mol Med Rep; 2014 Jan; 9(1):103-8. PubMed ID: 24247826
[TBL] [Abstract][Full Text] [Related]
13. MiR-429-5p attenuates the migration and invasion of malignant melanoma by targeting LIMK1.
Sheng H; Guo YH; Cao DS; Li XJ; Zhao Y; Ding H; Zhang YL; Chen ZH
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2625-2631. PubMed ID: 32196612
[TBL] [Abstract][Full Text] [Related]
14. LIMK1 and LIMK2 are important for metastatic behavior and tumor cell-induced angiogenesis of pancreatic cancer cells.
Vlecken DH; Bagowski CP
Zebrafish; 2009 Dec; 6(4):433-9. PubMed ID: 20047470
[TBL] [Abstract][Full Text] [Related]
15. miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1.
Xia H; Sun S; Wang B; Wang T; Liang C; Li G; Huang C; Qi D; Chu X
Int J Mol Sci; 2014 Jul; 15(7):11973-83. PubMed ID: 25003638
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of LIMK1-ADF/cofilin by DADS inhibits the migration and invasion of colon cancer.
Su J; Zhou Y; Pan Z; Shi L; Yang J; Liao A; Liao Q; Su Q
Sci Rep; 2017 Mar; 7():45624. PubMed ID: 28358024
[TBL] [Abstract][Full Text] [Related]
17. LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression.
Liao Q; Li R; Zhou R; Pan Z; Xu L; Ding Y; Zhao L
Br J Cancer; 2017 Aug; 117(4):563-571. PubMed ID: 28664914
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA Lnc-408 promotes invasion and metastasis of breast cancer cell by regulating LIMK1.
Qiao Y; Jin T; Guan S; Cheng S; Wen S; Zeng H; Zhao M; Yang L; Wan X; Qiu Y; Li Q; Liu M; Hou Y
Oncogene; 2021 Jun; 40(24):4198-4213. PubMed ID: 34079084
[TBL] [Abstract][Full Text] [Related]
19. MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1.
Zhao J; Li D; Fang L
Biomed Pharmacother; 2019 Jul; 115():108947. PubMed ID: 31078043
[TBL] [Abstract][Full Text] [Related]
20. LIMK1 depletion enhances fasudil-dependent inhibition of urethral fibroblast proliferation and migration.
Liang YC; Li XD; Wu YP; Ke ZB; Liu ZQ; Chen SH; Wei Y; Zheng QS; Xue XY; Xu N
J Cell Biochem; 2019 Aug; 120(8):12977-12988. PubMed ID: 30861189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
